Yüklüyor......
DRES-20. THE TNF RECEPTOR FAMILY MEMBER Fn14 IS HIGHLY EXPRESSED IN RECURRENT GLIOBLASTOMA (GBM) AND IN GBM PATIENT-DERIVED XENOGRAFTS WITH ACQUIRED TEMOZOLOMIDE RESISTANCE
INTRODUCTION: The current standard-of-care for patients with glioblastoma (GBM) consists of maximal safe surgical resection followed by high-dose radiation and concomitant oral chemotherapy using the DNA-alkylating agent temozolomide (TMZ). Despite this combination treatment, tumor recurrence is nea...
Kaydedildi:
| Yayımlandı: | Neuro Oncol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216626/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.327 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|